These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15317289)

  • 1. Potent non-peptide thrombin receptor antagonists.
    Chackalamannil S; Ahn HS; Xia Y; Doller D; Foster C
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):37-45. PubMed ID: 15317289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of potent peptide-mimetic antagonists for the human thrombin receptor, protease-activated receptor-1 (PAR-1).
    Maryanoff BE; Zhang HC; Andrade-Gordon P; Derian CK
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):13-36. PubMed ID: 15317288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist.
    Ahn HS; Foster C; Boykow G; Stamford A; Manna M; Graziano M
    Biochem Pharmacol; 2000 Nov; 60(10):1425-34. PubMed ID: 11020444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin receptor (PAR-1) antagonists. Heterocycle-based peptidomimetics of the SFLLR agonist motif.
    Hoekstra WJ; Hulshizer BL; McComsey DF; Andrade-Gordon P; Kauffman JA; Addo MF; Oksenberg D; Scarborough RM; Maryanoff BE
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1649-54. PubMed ID: 9873407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-peptidic small-molecule antagonists of the human platelet thrombin receptor PAR-1.
    Selnick HG; Barrow JC; Nantermet PG; Connolly TM
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):47-59. PubMed ID: 15317290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-derived protease-activated receptor-1 (PAR-1) antagonists.
    Seiler SM; Bernatowicz MS
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):1-11. PubMed ID: 15317287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents.
    Chackalamannil S; Xia Y; Greenlee WJ; Clasby M; Doller D; Tsai H; Asberom T; Czarniecki M; Ahn HS; Boykow G; Foster C; Agans-Fantuzzi J; Bryant M; Lau J; Chintala M
    J Med Chem; 2005 Sep; 48(19):5884-7. PubMed ID: 16161991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists.
    Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Lin Y; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Foster C; Bryant M; Lau J
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1544-8. PubMed ID: 16380251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterotricyclic himbacine analogs as potent, orally active thrombin receptor (protease activated receptor-1) antagonists.
    Chelliah MV; Chackalamannil S; Xia Y; Eagen K; Clasby MC; Gao X; Greenlee W; Ahn HS; Agans-Fantuzzi J; Boykow G; Hsieh Y; Bryant M; Palamanda J; Chan TM; Hesk D; Chintala M
    J Med Chem; 2007 Oct; 50(21):5147-60. PubMed ID: 17854166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1).
    Nantermet PG; Barrow JC; Lundell GF; Pellicore JM; Rittle KE; Young M; Freidinger RM; Connolly TM; Condra C; Karczewski J; Bednar RA; Gaul SL; Gould RJ; Prendergast K; Selnick HG
    Bioorg Med Chem Lett; 2002 Feb; 12(3):319-23. PubMed ID: 11814787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor.
    Andrade-Gordon P; Maryanoff BE; Derian CK; Zhang HC; Addo MF; Darrow AL; Eckardt AJ; Hoekstra WJ; McComsey DF; Oksenberg D; Reynolds EE; Santulli RJ; Scarborough RM; Smith CE; White KB
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12257-62. PubMed ID: 10535908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of peptide-mimetic protease-activated receptor-1 antagonists containing novel heterocyclic scaffolds.
    Severino B; Fiorino F; Perissutti E; Frecentese F; Cirino G; Roviezzo F; Santagada V; Caliendo G
    Bioorg Med Chem; 2008 Jun; 16(11):6009-20. PubMed ID: 18477511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of nor-seco himbacine analogs as thrombin receptor antagonists.
    Chelliah MV; Chackalamannil S; Xia Y; Eagen K; Greenlee WJ; Ahn HS; Agans-Fantuzzi J; Boykow G; Hsieh Y; Bryant M; Chan TM; Chintala M
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2544-9. PubMed ID: 22405832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ring.
    Xia Y; Chackalamannil S; Clasby M; Doller D; Eagen K; Greenlee WJ; Tsai H; Agans-Fantuzzi J; Ahn HS; Boykow GC; Hsieh Y; Lunn CA; Chintala M
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4509-13. PubMed ID: 17574850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivo.
    Perez M; Lamothe M; Maraval C; Mirabel E; Loubat C; Planty B; Horn C; Michaux J; Marrot S; Letienne R; Pignier C; Bocquet A; Nadal-Wollbold F; Cussac D; de Vries L; Le Grand B
    J Med Chem; 2009 Oct; 52(19):5826-36. PubMed ID: 19791800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
    Burke FM; Warnock M; Schmaier AH; Mosberg HI
    Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
    Kato Y; Kita Y; Nishio M; Hirasawa Y; Ito K; Yamanaka T; Motoyama Y; Seki J
    Eur J Pharmacol; 1999 Nov; 384(2-3):197-202. PubMed ID: 10611442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro pharmacological characterization of vorapaxar, a novel platelet thrombin receptor antagonist.
    Hawes BE; Zhai Y; Hesk D; Wirth M; Wei H; Chintala M; Seiffert D
    Eur J Pharmacol; 2015 Sep; 762():221-8. PubMed ID: 26022529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects.
    Chackalamannil S
    J Med Chem; 2006 Sep; 49(18):5389-403. PubMed ID: 16942011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.